CP
Camelot Portfolios’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-18,726
| Closed | -$716K | – | 246 |
|
|
2018
Q4 | $716K | Buy |
18,726
+236
| +1% | +$9.02K | 0.33% | 91 |
|
|
2018
Q3 | $743K | Sell |
18,490
-291
| -2% | -$11.7K | 0.33% | 83 |
|
|
2018
Q2 | $757K | Buy |
18,781
+10,688
| +132% | +$431K | 0.32% | 86 |
|
|
2018
Q1 | $801K | Sell |
8,093
-12,698
| -61% | -$1.26M | 0.37% | 76 |
|
|
2017
Q4 | $737K | Sell |
20,791
-290
| -1% | -$10.3K | 0.35% | 78 |
|
|
2017
Q3 | $856K | Buy |
21,081
+567
| +3% | +$23K | 0.41% | 69 |
|
|
2017
Q2 | $885K | Sell |
20,514
-272
| -1% | -$11.7K | 0.44% | 59 |
|
|
2017
Q1 | $876K | Buy |
20,786
+120
| +0.6% | +$5.06K | 0.43% | 65 |
|
|
2016
Q4 | $796K | Sell |
20,666
-9,283
| -31% | -$358K | 0.42% | 64 |
|
|
2016
Q3 | $1.29M | Buy |
29,949
+29
| +0.1% | +$1.25K | 0.69% | 42 |
|
|
2016
Q2 | $1.3M | Sell |
29,920
-131
| -0.4% | -$5.68K | 0.76% | 38 |
|
|
2016
Q1 | $1.22M | Buy |
30,051
+1,072
| +4% | +$43.5K | 0.75% | 40 |
|
|
2015
Q4 | $1.17M | Buy |
28,979
+5,626
| +24% | +$227K | 0.74% | 39 |
|
|
2015
Q3 | $898K | Buy |
23,353
+2,967
| +15% | +$114K | 0.6% | 46 |
|
|
2015
Q2 | $849K | Buy |
20,386
+1,293
| +7% | +$53.8K | 0.49% | 58 |
|
|
2015
Q1 | $881K | Buy |
+19,093
| New | +$881K | 0.51% | 52 |
|